Does ALPRAZOLAM Cause Psychomotor hyperactivity? 196 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 196 reports of Psychomotor hyperactivity have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.4% of all adverse event reports for ALPRAZOLAM.
196
Reports of Psychomotor hyperactivity with ALPRAZOLAM
0.4%
of all ALPRAZOLAM reports
0
Deaths
117
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From ALPRAZOLAM?
Of the 196 reports, 117 (59.7%) required hospitalization, and 18 (9.2%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 196 reports have been filed with the FAERS database.
What Other Side Effects Does ALPRAZOLAM Cause?
Drug abuse (8,827)
Toxicity to various agents (7,157)
Completed suicide (4,873)
Drug ineffective (4,040)
Overdose (2,967)
Drug dependence (2,743)
Somnolence (2,461)
Intentional overdose (2,389)
Death (2,317)
Suicide attempt (2,313)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which ALPRAZOLAM Alternatives Have Lower Psychomotor hyperactivity Risk?
ALPRAZOLAM vs ALPROSTADIL
ALPRAZOLAM vs ALTEPLASE
ALPRAZOLAM vs ALTERNARIA ALTERNATA
ALPRAZOLAM vs ALTHIAZIDE
ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE